Fanti S - Search Results

1

PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.

Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, Cho SY, Fanti S, Giesel FL, Goffin K, Haberkorn U, Jacene H, Koo PJ, Kopka K, Krause BJ, Lindenberg L, Marcus C, Mottaghy FM, Oprea-Lager DE, Osborne JR, Piert M, Rowe SP, Schöder H, Wan S, Wester HJ, Hope TA, Herrmann K. Fendler WP, et al. Among authors: fanti s. Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1466-1486. doi: 10.1007/s00259-022-06089-w. Epub 2023 Jan 5. Eur J Nucl Med Mol Imaging. 2023. PMID: 36604326 Free PMC article.

2

Role of 18F-FDG PET-CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients.

Nanni C, Rubello D, Castellucci P, Farsad M, Franchi R, Toso S, Barile C, Rampin L, Nibale O, Fanti S. Nanni C, et al. Among authors: fanti s. Eur J Nucl Med Mol Imaging. 2005 May;32(5):589-92. doi: 10.1007/s00259-004-1734-3. Epub 2005 Feb 22. Eur J Nucl Med Mol Imaging. 2005. PMID: 15726356 Clinical Trial.

3

(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours.

Ambrosini V, Nanni C, Zompatori M, Campana D, Tomassetti P, Castellucci P, Allegri V, Rubello D, Montini G, Franchi R, Fanti S. Ambrosini V, et al. Among authors: fanti s. Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):722-7. doi: 10.1007/s00259-009-1349-9. Epub 2010 Jan 27. Eur J Nucl Med Mol Imaging. 2010. PMID: 20107793

4

Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE.

Virgolini I, Ambrosini V, Bomanji JB, Baum RP, Fanti S, Gabriel M, Papathanasiou ND, Pepe G, Oyen W, De Cristoforo C, Chiti A. Virgolini I, et al. Among authors: fanti s. Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):2004-10. doi: 10.1007/s00259-010-1512-3. Eur J Nucl Med Mol Imaging. 2010. PMID: 20596866

5

Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?

Castellucci P, Fuccio C, Rubello D, Schiavina R, Santi I, Nanni C, Allegri V, Montini GC, Ambrosini V, Boschi S, Martorana G, Marzola MC, Fanti S. Castellucci P, et al. Among authors: fanti s. Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):55-63. doi: 10.1007/s00259-010-1604-0. Epub 2010 Sep 17. Eur J Nucl Med Mol Imaging. 2011. PMID: 20848281

6

The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.

Picchio M, Briganti A, Fanti S, Heidenreich A, Krause BJ, Messa C, Montorsi F, Reske SN, Thalmann GN. Picchio M, et al. Among authors: fanti s. Eur Urol. 2011 Jan;59(1):51-60. doi: 10.1016/j.eururo.2010.09.004. Epub 2010 Sep 15. Eur Urol. 2011. PMID: 20869161 Review.

7

Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study.

Fuccio C, Schiavina R, Castellucci P, Rubello D, Martorana G, Celli M, Malizia C, Profitos MB, Marzola MC, Pettinato V, Fanti S. Fuccio C, et al. Among authors: fanti s. Eur J Nucl Med Mol Imaging. 2011 Nov;38(11):1985-9. doi: 10.1007/s00259-011-1867-0. Epub 2011 Jul 6. Eur J Nucl Med Mol Imaging. 2011. PMID: 21732105

8

(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy.

Ceci F, Castellucci P, Mamede M, Schiavina R, Rubello D, Fuccio C, Ambrosini V, Boschi S, Martorana G, Fanti S. Ceci F, et al. Among authors: fanti s. Eur J Nucl Med Mol Imaging. 2013 Jan;40(2):149-55. doi: 10.1007/s00259-012-2272-z. Epub 2012 Nov 14. Eur J Nucl Med Mol Imaging. 2013. PMID: 23151910

9

The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques?

Schiavina R, Ceci F, Borghesi M, Brunocilla E, Vagnoni V, Gacci M, Castellucci P, Nanni C, Martorana G, Fanti S. Schiavina R, et al. Among authors: fanti s. Curr Radiopharm. 2013 Jun 6;6(2):92-5. doi: 10.2174/1874471011306020005. Curr Radiopharm. 2013. PMID: 23597246 Review.

10

11C-choline PET/CT scan in patients with prostate cancer treated with intermittent ADT: a sequential PET/CT study.

Ceci F, Schiavina R, Castellucci P, Brunocilla E, Fuccio C, Colletti PM, Ferretti A, Chondrogiannis S, Rubello D, Romagnoli D, Malizia C, Martorana G, Fanti S. Ceci F, et al. Among authors: fanti s. Clin Nucl Med. 2013 Jul;38(7):e279-82. doi: 10.1097/RLU.0b013e3182952c4c. Clin Nucl Med. 2013. PMID: 23698461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

704 results

Search Page